Guanhao Biotech Co.,Ltd.

300238

CNE100001575

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
9.91 ^CNY	+4.10%		+10.97%	-26.92%

Apr. 25	Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 05	Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guanhao Biotech Co.,Ltd. Announces Management Appointments

June 26, 2023 at 03:32 pm EDT

Guanhao Biotech Co.,Ltd. at its 2nd Extraordinary General Meeting of 2023 held on 21 June 2023 elected Deng Chao as independent director and Tian Dan as non-employee supervisors.

Latest news about Guanhao Biotech Co.,Ltd.

Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Guanhao Biotech Co.,Ltd. Announces Management Appointments	23-06-26	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Chinese Shares Finish Higher; Guanhao Biotech Rallies 20% on 500 Million Yuan Deal With Largest Shareholders	23-03-23	MT
Guanhao Biotech’s Actual Controllers to Boost Stake to 39% in 500 Million Yuan Deal; Shares Rally 20%	23-03-23	MT
Guanhao Biotech Co.,Ltd. announced that it expects to receive CNY 500 million in funding from Beijing Century Tianfu Venture Capital Center (Limited Partnership), Beijing Tianyou Investment Co., Ltd., Jiangsu Tianyou Jingan Investment Co., Ltd.	23-03-21	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-14	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-09	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-08	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI
Wuhan Constant Science & Technology Co., Ltd. cancelled the acquisition of 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd..	20-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-20	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-24	CI
Guanhao Biotech Co.,Ltd. Announces Board Changes	20-03-16	CI
Tibet Xinyi Investment Co., Ltd. cancelled the acquisition of 20% stake in Guangzhou Youvision Biotech Co., Ltd. from Guanhao Biotech Co.,Ltd..	20-01-23	CI
Wuhan Constant Science & Technology Co., Ltd. entered into an agreement to acquire 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd. for CNY 1.	19-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-24	CI

Chart Guanhao Biotech Co.,Ltd.

Duration

Period

More charts

Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GUANHAO BIOTECH CO.,LTD.	-26.92%	363M
ABBOTT LABORATORIES	-2.54%	186B
MEDTRONIC PLC	-1.85%	107B
BECTON, DICKINSON AND COMPANY	-4.26%	67.44B
DEXCOM, INC.	+1.39%	50.03B
CENCORA, INC.	+16.82%	47.81B
HOYA CORPORATION	+4.79%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	25.82B
TERUMO CORPORATION	+16.55%	24.74B

Other Medical Equipment, Supplies & Distribution